Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
110511123 | 11051112 | 3 | F | 20160802 | 20160802 | 20150421 | 20160805 | EXP | US-SA-2015SA050854 | AVENTIS | 88.00 | YR | E | M | Y | 0.00000 | 20160805 | PH | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
110511123 | 11051112 | 1 | PS | CEREZYME | IMIGLUCERASE | 1 | Intravenous drip | C6108Y01 | 20367 | 4800 | MG | POWDER FOR SOLUTION FOR INFUSION | QOW |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
110511123 | 11051112 | 1 | Gaucher's disease |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
110511123 | 11051112 | OT |
110511123 | 11051112 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
110511123 | 11051112 | Aortic valve disease | |
110511123 | 11051112 | Death | |
110511123 | 11051112 | General physical health deterioration |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
110511123 | 11051112 | 1 | 20070405 | 20160610 | 0 |